Development of a novel polycationic adsorbent for cryogel removal

Area of Science:

• Biochemistry
• Materials Science
• Medical Research

Background:

• Cryogel, a complex of plasma fibronectin (pFN) with extra domain A (EDA(+)FN) and fibrinogen (Fbg), forms in rheumatic patients' plasma due to heparin (HP) at low temperatures.
• EDA(+)FN presence in normal plasma is unusual, but its prevalence in rheumatism contributes to cryogelation, suggesting cryogel removal as a potential treatment.
• The HP-EDA(+)FN aggregate, a key cryogel component, exhibits anionic properties.

Purpose of the Study:

• To develop novel cationic materials for selectively removing the anionic HP-EDA(+)FN complex from plasma.
• To investigate the optimal amino group density on adsorbents for efficient cryogel component adsorption.
• To assess the therapeutic potential of cryogel removal in treating rheumatism.

Main Methods:

• Synthesis of cationic adsorbents with varying amino group densities.
• Testing the selective adsorption of the EDA(+)FN-HP complex using model patient plasma.
• Quantifying the removal efficiency of EDA(+)FN, pFN, and Fbg.

Main Results:

• Adsorbents with an amino group density of 100-130 micromol/g (dry weight) demonstrated selective adsorption of the EDA(+)FN-HP complex.
• An 80% elimination of EDA(+)FN was achieved.
• Significant removal of total fibronectin (pFN) (10%) and fibrinogen (Fbg) (10%) was also observed in model plasma.

Conclusions:

• Cationic materials with specific amino group densities can effectively and selectively remove cryogel components from plasma.
• This approach shows promise for developing novel therapeutic strategies targeting cryogel-related conditions like rheumatism.
• Further research is warranted to validate these findings in clinical settings.